A detailed history of Vanguard Group Inc transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Group Inc holds 1,306,432 shares of ANIP stock, worth $83.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,306,432
Previous 1,288,972 1.35%
Holding current value
$83.9 Million
Previous $71.1 Million 27.07%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$54.2 - $69.69 $946,332 - $1.22 Million
17,460 Added 1.35%
1,306,432 $90.3 Million
Q4 2023

Feb 14, 2024

BUY
$48.72 - $65.43 $7.63 Million - $10.2 Million
156,594 Added 13.83%
1,288,972 $71.1 Million
Q3 2023

Nov 14, 2023

BUY
$50.28 - $64.61 $2.93 Million - $3.76 Million
58,204 Added 5.42%
1,132,378 $65.7 Million
Q2 2023

Aug 14, 2023

BUY
$37.29 - $53.83 $8.95 Million - $12.9 Million
239,964 Added 28.77%
1,074,174 $57.8 Million
Q1 2023

May 15, 2023

BUY
$37.61 - $45.72 $811,849 - $986,911
21,586 Added 2.66%
834,210 $33.1 Million
Q4 2022

Feb 10, 2023

BUY
$31.9 - $41.95 $787,961 - $1.04 Million
24,701 Added 3.13%
812,624 $32.7 Million
Q3 2022

Nov 14, 2022

SELL
$29.83 - $38.01 $783,067 - $997,800
-26,251 Reduced 3.22%
787,923 $25.3 Million
Q2 2022

Aug 12, 2022

BUY
$23.09 - $33.46 $897,623 - $1.3 Million
38,875 Added 5.01%
814,174 $24.2 Million
Q1 2022

May 13, 2022

BUY
$26.91 - $47.15 $1.57 Million - $2.76 Million
58,523 Added 8.16%
775,299 $21.8 Million
Q4 2021

Feb 14, 2022

BUY
$32.97 - $56.85 $2.37 Million - $4.09 Million
71,962 Added 11.16%
716,776 $33 Million
Q3 2021

Nov 12, 2021

BUY
$26.48 - $35.99 $674,948 - $917,349
25,489 Added 4.12%
644,814 $21.2 Million
Q2 2021

Aug 13, 2021

BUY
$31.86 - $38.6 $19.7 Million - $23.9 Million
619,325 New
619,325 $21.7 Million

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.12B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.